A Study of LY2951742 in Participants With Episodic Cluster Headache

Condition:   Episodic Cluster Headache
Interventions:   Drug: LY2951742;   Drug: Placebo
Sponsor:   Eli Lilly and Company
Recruiting – verified September 2017
Source: ClinicalTrials.gov Listing of Cluster Headache trials
The main purpose of this study is to evaluate the efficacy and safety of the study drug known as LY2951742 in participants with episodic cluster headaches.